- Summits
- Sponsorship
- Media Opportunities
- News
- About
Malta is steadily emerging as a destination for healthcare innovation, driven by a clear national vision to establish itself at the center of the global health and life sciences ecosystem. Through the work of Malta Enterprise, the country is embracing advanced technologies such as artificial intelligence, the Internet of Things, and next-generation manufacturing methods to transform how healthcare solutions are developed, tested, and brought to market.
This strategy reflects Malta’s dual focus on supporting both established companies and emerging startups. The country’s MedTech and life sciences sectors already provide essential products and services to international markets, and Malta Enterprise continues to strengthen their global competitiveness. Alongside this, young and dynamic startups are being encouraged to bring new ideas, agility, and cutting-edge technologies into the ecosystem. Tailored incentives, mentorship opportunities, and business support initiatives are helping these innovators establish and scale operations within Malta, making the island an increasingly attractive base for health technology ventures.
“Our goal is to position Malta at the heart of global health innovation by fostering collaboration between research, technology, and enterprise,” said Mr. George Gregory, CEO of Malta Enterprise.
“We are committed to creating an ecosystem that supports both established players and emerging innovators who are shaping the next generation of healthcare solutions.”
Malta’s approach to healthcare innovation goes beyond traditional funding mechanisms. A strong emphasis is placed on collaboration between academia, healthcare institutions, and industry. Malta Enterprise plays an instrumental role in connecting local and international partners, including the University of Malta and Mater Dei Hospital, to foster the translation of research into practical healthcare applications.
Programs such as the Innovate and R&D Schemes are designed to move discoveries from the laboratory to the marketplace more efficiently. By enabling early engagement between researchers and companies, Malta creates a pipeline for innovation that leads to tangible outcomes—benefiting patients globally while contributing to sustainable economic growth at home.
One of Malta’s distinguishing strengths lies in its regulatory accessibility and supportive governance framework. The Malta Medicines Authority (MMA) has earned recognition as one of the leading regulators within the European Union, authorised to issue FDA certifications for US market access. This dual capability gives companies the assurance that their products meet both EU and US standards, simplifying their global expansion plans.
Complementing this, the Malta Digital Innovation Authority (MDIA) regulates and promotes the safe use of digital technologies. The MDIA’s regulatory sandbox provides a controlled environment for startups to develop and test emerging digital health solutions, with expert guidance from regulators. This framework promotes experimentation while maintaining patient safety and compliance, accelerating the path from concept to market readiness.
Malta’s membership in the European Union further amplifies these benefits. Companies operating from Malta enjoy streamlined access to the European market under harmonised standards, significantly reducing approval complexity and cost. For MedTech firms, this translates into faster, more efficient market entry and scalability across Europe and beyond.
Investor interest continues to grow, particularly in areas such as oncology research, digital health, and artificial intelligence. The Malta Life Sciences Park has become a focal point for advanced R&D, hosting international companies and collaborative projects in precision medicine and biotechnology. With support from Malta Enterprise, these initiatives are helping establish a diverse and forward-looking innovation ecosystem that aligns with global healthcare priorities.
While Malta’s MedTech and life sciences sectors have seen remarkable growth, challenges remain. The limited availability of specialised talent, the need for expanded R&D infrastructure, and access to funding are areas that require continued focus. Malta Enterprise is addressing these gaps through workforce training initiatives, relocation support for international professionals, and partnerships that connect local innovators with investors and funding networks.
Further priorities include strengthening data accessibility for clinical research while maintaining GDPR compliance and streamlining the clinical research approval process to accelerate development timelines. Such measures will help ensure that Malta remains an innovation-friendly environment where new technologies can reach patients faster and more efficiently.
As a long-standing partner, MedTech World continues to collaborate closely with Malta Enterprise to highlight the island’s growing prominence within the global health innovation community. The MedTech World Summit in Malta, held annually, serves as a central meeting point for global innovators, investors, and researchers. The event not only showcases Malta’s capabilities but also fosters cross-border collaboration, encouraging knowledge exchange and partnership development.
By attracting international participation and investment, MedTech World contributes to Malta’s ongoing journey toward becoming a preferred destination for MedTech innovation and commercialisation. Malta’s transformation into a vibrant center for healthcare innovation reflects a shared vision—one rooted in collaboration, technological progress, and a determination to deliver healthcare solutions that improve lives worldwide.
Join us at MedTech Malta 2025, taking place from 12 to 14 November, and be part of an international gathering that celebrates innovation, collaboration, and progress in healthcare. Get your tickets now.
